Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.11
0.126.03%
After Hours: 9:26 AM EDT
Comments
Loading...
Skye Bioscience Analyst Ratings and Price Targets | NASDAQ:SKYE | Benzinga
Skye Bioscience Inc has a consensus price target of $17.57 based on the ratings of 8 analysts. The high is $25 issued by Oppenheimer on April 12, 2024. The low is $14 issued by Craig-Hallum on March 21, 2025. The 3 most-recent analyst ratings were released by Craig-Hallum, Citizens Capital Markets, and Scotiabank on March 21, 2025, March 21, 2025, and September 30, 2024, respectively. With an average price target of $16.33 between Craig-Hallum, Citizens Capital Markets, and Scotiabank, there's an implied 661.46% upside for Skye Bioscience Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Craig-Hallum
Citizens Capital Markets
Scotiabank
Piper Sandler
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for Skye Bioscience
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/21/2025 | Buy Now | 552.68% | Craig-Hallum | Albert Lowe21% | $18 → $14 | Maintains | Buy | Get Alert |
| 03/21/2025 | Buy Now | 599.3% | Citizens Capital Markets | Jonathan Wolleben62% | $15 → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/28/2025 | Buy Now | — | William Blair | Andy Hsieh7% | — | Initiates | → Outperform | Get Alert |
| 09/30/2024 | Buy Now | 832.4% | Scotiabank | George Farmer39% | → $20 | Initiates | → Sector Outperform | Get Alert |
| 09/20/2024 | Buy Now | 832.4% | Piper Sandler | Edward Tenthoff50% | $20 → $20 | Reiterates | Overweight → Overweight | Get Alert |
| 09/20/2024 | Buy Now | 552.68% | Cantor Fitzgerald | Kristen Kluska69% | $14 → $14 | Reiterates | Overweight → Overweight | Get Alert |
| 09/10/2024 | Buy Now | 599.3% | JMP Securities | Jonathan Wolleben62% | → $15 | Initiates | → Market Outperform | Get Alert |
| 09/09/2024 | Buy Now | 552.68% | Cantor Fitzgerald | Kristen Kluska69% | $14 → $14 | Reiterates | Overweight → Overweight | Get Alert |
| 09/06/2024 | Buy Now | 552.68% | Cantor Fitzgerald | Kristen Kluska69% | $14 → $14 | Reiterates | Overweight → Overweight | Get Alert |
| 08/27/2024 | Buy Now | 552.68% | Cantor Fitzgerald | Kristen Kluska69% | $14 → $14 | Reiterates | Overweight → Overweight | Get Alert |
| 07/09/2024 | Buy Now | 739.16% | Craig-Hallum | Albert Lowe21% | → $18 | Initiates | → Buy | Get Alert |
| 07/01/2024 | Buy Now | 552.68% | Cantor Fitzgerald | Kristen Kluska69% | $14 → $14 | Reiterates | Overweight → Overweight | Get Alert |
| 06/18/2024 | Buy Now | 552.68% | Cantor Fitzgerald | Kristen Kluska69% | $14 → $14 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | Buy Now | 552.68% | Cantor Fitzgerald | Kristen Kluska69% | $14 → $14 | Reiterates | Overweight → Overweight | Get Alert |
| 05/23/2024 | Buy Now | 879.02% | Cantor Fitzgerald | Kristen Kluska69% | → $21 | Initiates | → Overweight | Get Alert |
| 04/12/2024 | Buy Now | 1065.5% | Oppenheimer | Jay Olson52% | → $25 | Initiates | → Outperform | Get Alert |
| 03/14/2024 | Buy Now | 832.4% | Piper Sandler | Edward Tenthoff50% | $12 → $20 | Reiterates | Overweight → Overweight | Get Alert |
| 02/05/2024 | Buy Now | 459.44% | Piper Sandler | Edward Tenthoff50% | → $12 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Skye Bioscience (SKYE) stock?
The latest price target for Skye Bioscience (NASDAQ:SKYE) was reported by Craig-Hallum on March 21, 2025. The analyst firm set a price target for $14.00 expecting SKYE to rise to within 12 months (a possible 552.68% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Skye Bioscience (SKYE)?
The latest analyst rating for Skye Bioscience (NASDAQ:SKYE) was provided by Craig-Hallum, and Skye Bioscience maintained their buy rating.
When was the last upgrade for Skye Bioscience (SKYE)?
There is no last upgrade for Skye Bioscience
When was the last downgrade for Skye Bioscience (SKYE)?
There is no last downgrade for Skye Bioscience.
When is the next analyst rating going to be posted or updated for Skye Bioscience (SKYE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Skye Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Skye Bioscience was filed on March 21, 2025 so you should expect the next rating to be made available sometime around March 21, 2026.
Is the Analyst Rating Skye Bioscience (SKYE) correct?
While ratings are subjective and will change, the latest Skye Bioscience (SKYE) rating was a maintained with a price target of $18.00 to $14.00. The current price Skye Bioscience (SKYE) is trading at is $2.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
